 Diabetes is a global epidemic with rising rates of prevalence in both developed and developing nations. Glycated hemoglobin, HbA1c, which measures the average level of sugar in the blood over the past few months, can be used as a reliable alternative to fasting blood glucose levels for diagnosing diabetes. It is also associated with increased risks of cardiovascular diseases and strokes, making it an important biomarker for assessing the health of diabetic patients. This article was offered by Sheree Gai Sherwani, Hasee Bae Khan, Aisha Iksemi, and others.